Literature DB >> 2181321

The heptad repeat in the largest subunit of RNA polymerase II binds by intercalating into DNA.

M Suzuki1.   

Abstract

A TANDEM repeat of the sequence Ser-Pro-Thr-Ser-Pro-Ser-Tyr has been found at the C terminus in the largest subunit of RNA polymerase II (refs 1-5) with, for example, 26 units in yeast and 52 in mammals. By removal of this 'tail', it has been shown that 11-23 units are necessary for the normal functioning of the polymerase. The functional role of the repeat is however, unclear, although it has been proposed that it binds to transcription factors. As discussed in an earlier paper, the repeat unit contains two Ser-Pro sequences which seem to be related to a DNA-binding unit found in histones, Ser-Pro-Lys-Lys, and to the Ser-Pro-X-X motif which is often found in gene regulatory proteins and which, it has been proposed, is also a DNA-binding unit. Here, I show that the repeat does indeed bind DNA and present evidence that it does so by the intercalation of tyrosine residues. These experiments involved synthetic peptides containing one or two repeat units. As the sequence Ser-Pro-X-X (where X represents any amino acid) has a strong tendency to assume a special beta-turn, a model of the unit composed of two such beta-turns was made and compared with the structure of the drug Triostin A which is known to intercalate into DNA. Two tyrosine side chains of the repeat overlap well with two quinoxaline rings of the drug and therefore, the model can provide a good explanation of the experimental results.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181321     DOI: 10.1038/344562a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

1.  A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure.

Authors:  E Shtivelman; F E Cohen; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 2.  Tailored tails and transcription initiation: the carboxyl terminal domain of RNA polymerase II.

Authors:  D M Chao; R A Young
Journal:  Gene Expr       Date:  1991-04

Review 3.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

4.  Variable pause positions of RNA polymerase II lie proximal to the c-myc promoter irrespective of transcriptional activity.

Authors:  D A Wolf; L J Strobl; A Pullner; D Eick
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

5.  Interplay of positive and negative effectors in function of the C-terminal repeat domain of RNA polymerase II.

Authors:  Y Li; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

6.  The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II.

Authors:  A B Buermeyer; N E Thompson; L A Strasheim; R R Burgess; P J Farnham
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

7.  The RNA polymerase I transcription factor xUBF contains 5 tandemly repeated HMG homology boxes.

Authors:  D Bachvarov; T Moss
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

8.  The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.

Authors:  M von Lindern; M Fornerod; S van Baal; M Jaegle; T de Wit; A Buijs; G Grosveld
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

9.  The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates.

Authors:  T B Fu; J Taylor
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation.

Authors:  Young Kyeung Kim; Cyril F Bourgeois; Catherine Isel; Mark J Churcher; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.